The molecular mechanism behind polycystic liver disease. And the allele that went missing…
20-3-2013, M.J. Janssen
Pathogenesis and reversal of liver fibrosis, effects of genes and environment
28-2-2013, A. Sokolović
Long-term Clinical Outcome of Antiviral Therapy for Chronic Hepatitis B
21-12-2012, R. Zoutendijk
Human liver cell lines for the AMC-bioartificial liver
23-11-2012, G. Nibourg
Neuropsychiatric and other side effects of Peginterferon-based therapy of chronic hepatitis C
20-6-2012, G. Bezemer
Gene Therapy with Adeno-Associated Viral Vectors for Inherited Hyperbilirubinemia: Towards a Clinical Trial for Crigler-Najjar Syndrome
9-5-2012, P. de Sousa Montenegro Miranda
Signal transduction pathways in hepatocyte cell death: New targets for therapy
7-5-2012, G. Karimian
DLK1 and the Notch pathway in the liver
23-2-2012, F. Falix
Novel Anti-viral Strategies for Hepatitis C
22-2-2012, Q. Pan
Getting grip on glucocorticoid-induced metabolic derangements
8-2-2012, A. Laskewitz